Introduction
Sclerostin Domain Containing 1 (SOSTDC1), a member of the sclerostin family, is a secreted N-glycosylated protein with a C-terminal cystine knot-like domain. Functioning as a bone morphogenetic protein (BMP) antagonist, SOSTDC1 directly interacts with BMPs, preventing them from binding to their receptors. This interaction regulates BMP signaling pathways involved in cellular processes like proliferation, differentiation, and apoptosis. SOSTDC1 is also believed to play a role in endometrial receptivity for implantation and sensitization for the decidual cell reaction. It enhances Wnt signaling while inhibiting TGF-beta signaling. Additionally, SOSTDC1 directly antagonizes the activity of BMP2, BMP4, BMP6, and BMP7 in a dose-dependent manner.
Description
Recombinant human SOSTDC1, produced in E. coli, is a single, non-glycosylated polypeptide chain comprising 206 amino acids (24-206 a.a). It has a molecular mass of 23 kDa. The protein consists of SOSTDC1 fused to a 23 amino acid His-tag at the N-terminus. It is purified using proprietary chromatographic techniques.
Physical Appearance
A sterile, colorless solution.
Formulation
The SOSTDC1 protein solution (1 mg/ml) is supplied in a buffer containing 20 mM Tris-HCl (pH 8.0), 0.4 M urea, and 10% glycerol.
Stability
For short-term storage (up to 2-4 weeks), keep at 4°C. For extended storage, freeze at -20°C. Adding a carrier protein (0.1% HSA or BSA) is recommended for long-term storage. Avoid repeated freeze-thaw cycles.
Purity
Purity is determined to be greater than 85.0% by SDS-PAGE analysis.
Synonyms
Sclerostin domain-containing protein 1, Ectodermal BMP inhibitor, Ectodin, Uterine sensitization-associated gene 1 protein, USAG-1, SOSTDC1, USAG1, CDA019.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MGSFKNDATE ILYSHVVKPV PAHPSSNSTL NQARNGGRHF SNTGLDRNTR VQVGCRELRS TKYISDGQCT SISPLKELVC AGECLPLPVL PNWIGGGYGT KYWSRRSSQE WRCVNDKTRT QRIQLQCQDG STRTYKITVV TACKCKRYTR QHNESSHNFE SMSPAKPVQH HRERKRASKS SKHSMS.